<DOC>
	<DOCNO>NCT00800956</DOCNO>
	<brief_summary>The purpose study learn esreboxetine handle body i.e . absorption , metabolism excretion esreboxetine .</brief_summary>
	<brief_title>Phase I Study Determine Absorption , Distribution , Metabolism Excretion Esreboxetine</brief_title>
	<detailed_description />
	<criteria>Healthy male subject age 45 65 year Body mass index ( BMI=weight/height2 ) 18 30 kg/m2 Any clinically relevant abnormality identify screen medical assessment Any condition possibly affect drug absorption Subjects exposure significant radiation ( eg serial Xray CT scan , barium meal etc ) participate radiolabelled study past 12 month , occupational exposure radioactivity History regular alcohol consumption exceed 14 drinks/week ( 1 drink = 5ounces ( 150ml ) wine 12 ounce ( 360ml ) beer 1.5 ounce ( 45ml ) hard liquor ) within 6 month screen 12lead ECG demonstrate QTc &gt; 450mses screen Treatment investigational drug within 30 day 5 halflives precede first dose study medication</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Radiolabel ADME study Healthy volunteer</keyword>
</DOC>